BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Dendritic cell-specific ICAM-3 grabbing nonintegrin (DC-SIGN; CD209)

January 21, 2016 8:00 AM UTC

Cell culture studies identified a DC-SIGN-binding glycofullerene that could help treat Ebola. The compound consisted of a core 60-carbon fullerene ([60]fullerene) linked to 12 additional [60]fullerene...